Jennifer Compton, PA
Physician Assistant · Tulsa, OKNPI 1174560361
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,307 of the $12,273 with a category attached, or 84.0%. It is spread thinly across 38 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,198 and has fallen 61.5% since, to $1,231 in 2025. Among physician assistant clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 655 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Axonics, Inc.$2K
- Sumitomo Pharma America, Inc.$1K
- Astellas Pharma US Inc$1K
- Coloplast$800
- plus $4K from 32 others
What the payments were for
- Consulting fees$7886%
- Travel & lodging$9238%
- Food & beverage$10,30784%
- Education$2552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 96 | $2,039 |
| Johnson & Johnson(2 entities) | 70 | $1,565 |
| Axonics, Inc. | 15 | $1,532 |
| Sumitomo Pharma America, Inc. | 167 | $1,117 |
| Astellas Pharma US Inc | 53 | $1,040 |
| Coloplast | 43 | $800 |
| Pfizer | 35 | $764 |
| Boston Scientific | 20 | $396 |
| Medtronic | 8 | $377 |
| Urovant Sciences Inc | 23 | $337 |
| Antares Pharma, Inc. | 17 | $289 |
| Urogen Pharma, Inc. | 10 | $223 |
| Myriad Genetic Laboratories, Inc. | 12 | $218 |
| Teleflex LLC | 7 | $139 |
| Myovant Sciences Inc. | 7 | $133 |
| Merck | 8 | $132 |
| Bayer | 6 | $123 |
| Clarus Therapeutics Inc. | 8 | $106 |
| Novartis | 4 | $98 |
| Endo Pharmaceuticals Inc. | 7 | $96 |
| Ferring Pharmaceuticals Inc. | 4 | $85 |
| Travere Therapeutics, Inc. | 4 | $82 |
| Blue Earth Diagnostics | 4 | $79 |
| Halozyme Inc | 4 | $65 |
| Procept Biorobotics Corporation | 3 | $63 |
| Endo USA, Inc. | 3 | $57 |
| Vertex | 2 | $55 |
| Hollister Incorporated | 2 | $48 |
| Progenics Pharmaceuticals, Inc. | 2 | $45 |
| Accord Healthcare, Inc. | 2 | $29 |
| Civco Medical Instruments | 1 | $24 |
| Sanofi | 1 | $23 |
| Immunitybio, Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $12 |
| Laborie Medical Technologies Corp. | 2 | $12 |
| Convatec Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,273 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 538 | $451,685 |
| MyrbetriqMirabegron | 313 | $227,619 |
| Estradiol | 292 | $16,648 |
| Trospium Chloride | 142 | $10,365 |
| Tamsulosin Hcl | 484 | $8,795 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 189 | $5,896 |
| Trimethoprim | 76 | $5,401 |
| Finasteride | 224 | $4,827 |
| Cephalexin | 354 | $3,134 |
| OsphenaOspemifene | 11 | $2,582 |
| Solifenacin Succinate | 50 | $2,041 |
| Methenamine Hippurate | 29 | $1,476 |
| Ciprofloxacin Hcl | 147 | $1,440 |
| Clobetasol Propionate | 18 | $1,153 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 25 | $1,091 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $1,117 | $451,685538 claims |
| Astellas Pharma US IncMyrbetriq | $1,040 | $227,619313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Tulsa
- Matthew PattonTulsa$24K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
- Jenny BirksTulsa$13K
- Andrea BellassaiTulsa$12K
- Adrian DonnellyTulsa$12K
- Valerie TerrellTulsa$12K
- Lori RuleTulsa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.